Robert J Chilton (Robert Chilton)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 7

Top Topics

Acute Heart Failure

Glycemic Control

Low Density Lipoprotein

Clinical Practice

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Chilton
Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure. Diabetes, obesity & metabolism 23 (5) (2021)
Robert J Chilton
Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes. Diabetes, obesity & metabolism 22 (1) (2019)
Robert J Chilton, Rene Oliveros, Kelly M Gallegos, Son Pham
PCSK9 inhibitors and diabetes: Translational biology to clinical practice. Diabetes, obesity & metabolism 21 (3) (2019)
Mariam Alatrach, Christina Agyin, John Adams, Robert J Chilton, Curtis Triplitt, Muhammad Abdul-Ghani, Eugenio Cersosimo
Glucose lowering and vascular protective effects of cycloset added to GLP-1 receptor agonists in patients with type 2 diabetes. Endocrinology, diabetes & metabolism 1 (4) (2018)
Geoffrey D Clarke, Marjorie Molina-Wilkins, Carolina Solis-Herrera, Verna Mendez, Adriana Monroy, Eugenio Cersosimo, Robert J Chilton, Muhammad A Abdul-Ghani, Muhammad Abdul-Ghani
Impaired left ventricular diastolic function in T2DM patients is closely related to glycemic control. Endocrinology, diabetes & metabolism 1 (2) (2018)
Stephano Del Prato, Robert J Chilton
Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors. Diabetes, obesity & metabolism 20 (4) (2017)
Robert J Chilton, Ilkka Tikkanen, Uwe Hehnke, Hans J Woerle, Odd Erik Johansen
Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension. Diabetes, obesity & metabolism 19 (11) (2017)